Literature DB >> 23609173

Acute coronary syndromes. STREAMlining care for patients with STEMI.

Akshay Bagai1, Christopher B Granger.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23609173     DOI： 10.1038/nrcardio.2013.62

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  9 in total

1.  Expansion of a regional ST-segment-elevation myocardial infarction system to an entire state.

Authors:  James G Jollis; Hussein R Al-Khalidi; Lisa Monk; Mayme L Roettig; J Lee Garvey; Akinyele O Aluko; B Hadley Wilson; Robert J Applegate; Greg Mears; Claire C Corbett; Christopher B Granger
Journal:  Circulation       Date:  2012-06-04       Impact factor: 29.690

2.  Reperfusion paradox in ST-segment elevation myocardial infarction.

Authors:  Paul W Armstrong; William E Boden
Journal:  Ann Intern Med       Date:  2011-09-20       Impact factor: 25.391

3.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao; Jeffrey L Anderson; Alice K Jacobs; Jonathan L Halperin; Nancy M Albert; Ralph G Brindis; Mark A Creager; David DeMets; Robert A Guyton; Judith S Hochman; Richard J Kovacs; Frederick G Kushner; E Magnus Ohman; William G Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2012-12-17       Impact factor: 29.690

4.  Timely PCI for STEMI--still the treatment of choice.

Authors:  Deepak L Bhatt
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 91.245

5.  The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times.

Authors:  Emil L Fosbol; Christopher B Granger; James G Jollis; Lisa Monk; Li Lin; Barbara L Lytle; Ying Xian; J Lee Garvey; Greg Mears; Claire C Corbett; Eric D Peterson; Seth W Glickman
Journal:  Circulation       Date:  2012-12-30       Impact factor: 29.690

6.  Use of emergency medical service transport among patients with ST-segment-elevation myocardial infarction: findings from the National Cardiovascular Data Registry Acute Coronary Treatment Intervention Outcomes Network Registry-Get With The Guidelines.

Authors:  Robin Mathews; Eric D Peterson; Shuang Li; Matthew T Roe; Seth W Glickman; Stephen D Wiviott; Jorge F Saucedo; Elliott M Antman; Alice K Jacobs; Tracy Y Wang
Journal:  Circulation       Date:  2011-06-20       Impact factor: 29.690

7.  Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.

Authors:  Giuseppe De Luca; Harry Suryapranata; Jan Paul Ottervanger; Elliott M Antman
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.

Authors:  Paul W Armstrong; Anthony H Gershlick; Patrick Goldstein; Robert Wilcox; Thierry Danays; Yves Lambert; Vitaly Sulimov; Fernando Rosell Ortiz; Miodrag Ostojic; Robert C Welsh; Antonio C Carvalho; John Nanas; Hans-Richard Arntz; Sigrun Halvorsen; Kurt Huber; Stefan Grajek; Claudio Fresco; Erich Bluhmki; Anne Regelin; Katleen Vandenberghe; Kris Bogaerts; Frans Van de Werf
Journal:  N Engl J Med       Date:  2013-03-10       Impact factor: 176.079
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.